Seth Klarman: portfolio of Baupost Group

Seth Klarman leads the Baupost Group, which follows a value approach and looks for securities trading below their estimated worth.

Source: 13F filing with the US Securities and Exchange Commission dated May 15, 2015. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q1 2015. Go to the latest filing (Q3 2026)

5.9B USDQ1 2015
Total value of stock positions
5.9B USD
Positions
27
Share of the ten largest
80.7%

The ten largest positions Q1 2015

  1. Cheniere Energy Inc 18.1%unchanged
  2. Viasat Inc 11.6%unchanged
  3. eBay Inc. 9.1%unchanged
  4. Micron Technology 9.0%unchanged
  5. Pioneer Nat Res Co 8.8%new
  6. Antero Res Corp 5.6%▲ +19.1%
  7. Theravance Inc 5.3%unchanged
  8. Pbf Energy Inc 5.0%unchanged
  9. Keryx Biopharmaceuticals Inc 4.8%▲ +22.3%
  10. Sunedison Semiconductor Ltd 3.5%▲ +90.5%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 12.7B USD).
Choose a quarter (54 filings)

All positions Q1 2015

Positions Q1 2015 per 13F filing, 8 of 8
Symbol Weight Shares Reported value Change Held since
American Intl Group Inc 0.5% 1,254,750 27.5M USD +41.1% increased Q2 2013 or earlier 8 quarters
Keryx Biopharmaceuticals Inc 4.8% 22,380,200 284.9M USD +22.3% increased Q1 2014 5 quarters
Sunedison Semiconductor Ltd 3.5% 7,897,979 203.9M USD +90.5% increased Q2 2014 4 quarters
Theravance Biopharma Inc 1.9% 6,366,577 110.5M USD +5.0% increased Q2 2014 4 quarters
Antero Res Corp 5.6% 9,347,700 330.2M USD +19.1% increased Q3 2014 3 quarters
Ocwen Finl Corp 1.1% 7,833,884 64.6M USD +31.3% increased Q3 2014 3 quarters
Atara Biotherapeutics Inc 3.3% 4,763,265 192.8M USD +90.8% increased Q4 2014 2 quarters
Bellatrix Exploration Ltd 0.9% 21,840,500 53.1M USD +20.6% increased Q4 2014 2 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 1 position in convertible bonds and bonds worth 41.2M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Theravance Inc principal 48.2M USD 41.2M USD

Breakdown by sector

  • Consumer Discretionary 9.1%
  • Technology 9.0%
  • not in our coverage 81.9%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close